S-ECCO
15June2022

The aftermath of the pandemic

Pär Myrelid, S-ECCO Member

Pär Myrelid
© ECCO

By now we are all hoping that the cases of COVID-19 that we still see represent the beginning of the end of the pandemic. For more than two years, the health care system has been overloaded globally and the whole world has been suffering. Initially we struggled with severely ill COVID-19 patients filling up ICU wards at more or less every hospital, and in addition theatre staff were often asked to help out with COVID-19 patients rather than assisting in theatres. At some hospitals the theatres were turned into extra ICU wards. This was made easier by the fact that during the early days of the pandemic the normal emergency cases seemed to have disappeared. Just like prior to a tsunami, where the water withdraws before the giant wave hits, the emergency rooms were left empty for some days or even weeks. A deceptive calmness soon gave way to chaos.

Posted in ECCO News, Committee News, S-ECCO, Volume 17, Issue 2

28April2022

Report on the 11th S-ECCO IBD Masterclass

Christianne Buskens, S-ECCO Chair

Christianne Buskens
© ECCO

In contrast to what we had hoped, the 11th S-ECCO Masterclass was again a virtual event due to the ongoing COVID-19 pandemic. However, as everyone has slowly got used to online conferences, it almost felt intimate to meet like this once more.

Posted in ECCO News, Committee News, Congress News, S-ECCO, ECCO'22, Volume 17, Issue 1

16December2021

Surgical training

Pär Myrelid, S-ECCO Member

Pär Myrelid
© ECCO

Many technical innovations are facilitating the education process involved in training a skilled surgeon today. At the same time, this process is in many ways still a joint collaboration between a master and his/her apprentice, and will continue to be so. Fruitful training in any practical setting is based on trust, from both parties, in combination with application of the experience of the master in order to sort out any perioperative complications. Beyond acquisition of the necessary technical skill, becoming a surgeon requires the development of a sound understanding of when to operate and when not to, as well as the ability to choose the right surgical option. This is, of course, important in all surgical fields but it is perhaps especially true within the field of Inflammatory Bowel Disease (IBD).

Posted in ECCO News, Committee News, S-ECCO, Volume 16, Issue 4

25March2021

Impact of COVID-19 on surgical IBD care

Michel Adamina, S-ECCO Chair on behalf of Christianne Buskens, Omar Faiz, Pår Myrelid, Hagit Tulchinsky

Michel Adamina
© ECCO

For the past year the COVID-19 pandemic has raged across the world, with wave after wave of the disease. No country has been spared and no end is in sight in the near future. A recent position paper from the ECCO COVID-19 Taskforce presented the ten ‘dos and don’ts’ when caring for IBD patients. S-ECCO Members are involved in the specialised surgical care of IBD patients in many countries and a variety of institutions. Hence, we are offering this opinion piece on the performance of IBD surgery during the pandemic.

Posted in ECCO News, Committee News, S-ECCO, Volume 16, Issue 1

15December2020

High Performance in IBD Surgery

Omar Faiz, S-ECCO Member

Omar Faiz
© ECCO

High performance in surgery has been the subject of discussion for a number of years. In IBD surgery it’s been what you might call a ‘shaggy dog’ story. For those of you unfamiliar with this term – there is an entire Wiki page dedicated to it [1]. High performance in IBD surgery has, thus far, fulfilled the criteria for such a story perfectly – it’s: long-winded, anecdotal, arguably failed to reach relevance and a bit of an anti-climax – all the essential ingredients.

Posted in ECCO News, Committee News, S-ECCO, Volume 15, Issue 4

30September2020

14th European Colorectal Congress of St.Gallen

Michel Adamina, S-ECCO Chair

Note: Due to the COVID-19 pandemic, the 14th European Colorectal Congress will be virtual. The article below was submitted prior to this decision. Please refer to the ECC Congress website to check on the latest update.

Michel Adamina
© ECCO

The 14th European Colorectal Congress opens on Sunday, November 29, 2020 with a Masterclass in Colorectal Surgery and a Course in Proctology, followed by three days of expert lectures until the Congress closes on Wednesday, December 2, 2020. A carefully devised safety approach overseen by the Swiss health authorities is allowing the organisation of this large European meeting, traditionally attended by more than 1000 participants from 80 countries who travel to the St.Gallen Colorectal Week (www.colorectalsurgery.eu, @ECCongress). Michel Adamina, from S-ECCO, is co-organising the meeting.

Posted in ECCO News, Committee News, S-ECCO, Volume 15, Issue 3

12March2020

Report on the 9th S-ECCO IBD Masterclass at ECCO'20

Yves Panis, Past S-ECCO Chair

Yves Panis
© ECCO

The 9th S-ECCO Masterclass (held in collaboration with the European Association of Coloproctology, ESCP) was organised during the 15th Congress of ECCO in Vienna. Thankfully, just before the coronavirus crisis!

As in previous years, it was a full-day masterclass, and once again it attracted a large number of participants, 149. This meant that in terms of attendance the S-ECCO Masterclass was second among all masterclasses and symposia, just after the N-ECCO Network Meeting.

Posted in ECCO News, Committee News, Congress News, ECCO'20, S-ECCO, Volume 15, Issue 1

17December2019

Does the expanding armamentarium of medical options in IBD result in postponement of colectomy with an increased incidence of dysplasia and colorectal cancer?

Christianne Buskens, S-ECCO Member and Awardee of the ECCO-Pfizer Research Award 2019

Christianne Buskens
© ECCO

Patients with Inflammatory Bowel Disease (IBD) have an increased risk of colorectal cancer (CRC), principally resulting from the pro-neoplastic effects of chronic intestinal inflammation [1]. Epidemiological studies, however, have suggested that the incidence of CRC has decreased over time [2]. This is partly because the estimated incidence in older studies was based on data from referral centres, which likely included a different patient population with more severe and complicated disease. The declining incidence has also been attributed to successful CRC surveillance programmes and in addition has been hypothesised to be a consequence of improved control of mucosal inflammation [3]. The expanding armamentarium of medical options in IBD, such as anti-TNF and anti-adhesion biologic therapies, has substantially improved our ability to control severe inflammation, theoretically decreasing the risk of CRC.

Posted in ECCO News, Committee News, S-ECCO, Volume 14, Issue 4

17December2019

6th S-ECCO IBD International Workshop, Curitiba, Brazil August 29–31, 2019

Paulo Gustavo Kotze, EduCom Member

Paulo Gustavo Kotze
© ECCO

The Surgeons of ECCO (S-ECCO) once more organised an international workshop outside of Europe. These international workshops constitute a tradition in Latin America, with previous meetings having been held in Brazil, Mexico and Colombia since 2013. This year, the meeting was held in Curitiba, the capital of the state of Paraná, in southern Brazil. This meeting was the result of a cooperation between ECCO and GEDIIB, the Brazilian Study Group of IBD.

Posted in ECCO News, Committee News, S-ECCO, Volume 14, Issue 4

11October2019

13th European Colorectal Congress of St. Gallen

Michel Adamina, S-ECCO Member

Michel AdaminaMichel Adamina
© ECCO

The 13th European Colorectal Congress starts on Sunday December 1, 2019 with a Masterclass in Colorectal Surgery and ends on Thursday December 5, 2019. About 1,400 participants from 80 countries are expected to attend the St. Gallen Colorectal Week (www.colorectalsurgery.eu, @ECCongress). Michel Adamina, from S-ECCO, is co-organising the meeting.

Posted in ECCO News, Committee News, S-ECCO, Volume 14, Issue 3